Related Experiment Video
Updated: Jul 25, 2025

Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis
Published on: October 27, 2023
COVID-19 Associated Mucormycosis
Sana Tazeem1, A Nagaraju2, Hazeera Begum3
1Osmania Medical College, Hyderabad, India.
Abstract:
Mucormycosis is a life-threatening opportunistic fungal infection seen in immunocompromised states. Rising incidence of mucormycosis among Coronavirus Disease-2019 infected individuals is an increasing concern in India. The disease which was endemic has blown out to become an epidemic. The purpose of this research is to study the epidemiology, management and outcome of Coronavirus Disease-2019 Associated Mucormycosis (CAM) cases. Additionally, the role of diabetes and steroids in the causation of CAM was determined. A hospital-based observational study was conducted at a tertiary care centre involving cases with rhino-orbital mucormycosis with recent history of COVID-19 infection. Out of 205,166(81%) cases had Diabetes Mellitus as a comorbid condition. Among them, 75(36.6%) cases were diagnosed with diabetes during COVID-19 treatment. 161/205(78.5%) cases received corticosteroids during COVID-19 treatment. Corticosteroids were notindicated in 43(26.7%) cases. 177/205(85.4%) cases were alive at the end of 12 weeks. 8 out of 10 deaths were seen in cases having diabetes. As the incidence of mucormycosis is increasing, better awareness among general population about the disease, early diagnosis and multidisciplinary approach is required to improve prognosis.
Insights
The study found that Coronavirus Disease-2019 Associated Mucormycosis (CAM) is an epidemic in India, often linked to diabetes and steroid use during COVID-19 treatment. Early diagnosis and multidisciplinary care are crucial for improving outcomes in these fungal infections.
Area of Science:
- Infectious Diseases
- Mycology
- Epidemiology
Background:
- Mucormycosis is a severe opportunistic fungal infection prevalent in immunocompromised individuals.
- The incidence of mucormycosis has surged among Coronavirus Disease-2019 (COVID-19) patients in India, escalating from endemic to epidemic levels.
- Diabetes and corticosteroid use are significant risk factors associated with COVID-19-related mucormycosis.
Purpose of the Study:
- To investigate the epidemiology, management strategies, and patient outcomes of COVID-19 Associated Mucormycosis (CAM).
- To determine the specific roles of diabetes mellitus and corticosteroid administration in the development of CAM.
Main Methods:
- A hospital-based observational study was conducted at a tertiary care facility.
- The study included patients diagnosed with rhino-orbital mucormycosis and a recent history of COVID-19 infection.
- Data on comorbidities, treatment, and outcomes were collected and analyzed.
Main Results:
- Out of 205 patients, 81% had Diabetes Mellitus, with 36.6% diagnosed during COVID-19 treatment.
- Corticosteroids were administered to 78.5% of patients, often inappropriately (26.7%).
- Mortality was higher in diabetic patients, with 80% of deaths occurring in this subgroup; 85.4% of all patients survived 12 weeks.
Conclusions:
- COVID-19 Associated Mucormycosis presents a significant public health challenge in India, characterized by high rates of diabetes and corticosteroid use.
- Effective management requires increased public awareness, prompt diagnosis, and a collaborative, multidisciplinary approach to improve patient prognosis.
- Addressing the underlying risk factors, particularly diabetes control and judicious steroid use, is critical in combating this devastating infection.
More Related Videos
15:01Confocal Laser Scanning Microscopy-Based Quantitative Analysis of Aspergillus fumigatus Conidia Distribution in Whole-Mount Optically Cleared Mouse Lung
Published on: September 18, 2021
08:02Th17 Inflammation Model of Oropharyngeal Candidiasis in Immunodeficient Mice
Published on: February 18, 2015
Related Concept Videos
Fungal Group Zygomycota
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Fungal Phylum Microsporidia
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...